Quantitative Structure–Activity Relationships of Heterocyclic Topoisomerase Iand II Inhibitors
暂无分享,去创建一个
[1] R. Hertzberg,et al. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. , 1985, The Journal of biological chemistry.
[2] M. Abraham,et al. The use of characteristic volumes to measure cavity terms in reversed phase liquid chromatography , 1987 .
[3] D. E. Patterson,et al. Crossvalidation, Bootstrapping, and Partial Least Squares Compared with Multiple Regression in Conventional QSAR Studies , 1988 .
[4] L. Liu,et al. DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues. , 1989, Cancer research.
[5] R. Agarwal,et al. Green tea in chemoprevention of cancer. , 1992, Comprehensive therapy.
[6] L. Moore,et al. Plant antitumor agents. 30. Synthesis and structure activity of novel camptothecin analogs. , 1993, Journal of medicinal chemistry.
[7] N. Osheroff,et al. When good enzymes go bad: conversion of topoisomerase II to a cellular toxin by antineoplastic drugs. , 1993, Chemical research in toxicology.
[8] F. Zunino,et al. Conformational drug determinants of the sequence specificity of drug-stimulated topoisomerase II DNA cleavage. , 1994, Journal of molecular biology.
[9] Y. Pommier,et al. Topoisomerase II inhibition and cytotoxicity of the anthrapyrazoles DuP 937 and DuP 941 (Losoxantrone) in the National Cancer Institute preclinical antitumor drug discovery screen. , 1994, Journal of the National Cancer Institute.
[10] D. Mcclernon,et al. Selective inhibition of topoisomerases from Pneumocystis carinii compared with that of topoisomerases from mammalian cells , 1994, Antimicrobial Agents and Chemotherapy.
[11] T. Corbett,et al. 3-benzyl-quinolones: Novel, potent inhibitors of mammalian topoisomerase II☆ , 1995 .
[12] M. Eissenstat,et al. Potent mammalian topoisomerase II inhibitors: 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)-4-substituted-quinolines , 1995 .
[13] Q. Sun,et al. Synthesis and evaluation of terbenzimidazoles as topoisomerase I inhibitors. , 1995, Journal of medicinal chemistry.
[14] N. Osheroff,et al. Topoisomerase Poisons: Harnessing the Dark Side of Enzyme Mechanism (*) , 1995, The Journal of Biological Chemistry.
[15] L. Pogliani. Modeling with Special Descriptors Derived from a Medium-Sized Set of Connectivity Indices , 1996 .
[16] H. Gogas,et al. New drugs. The anthrapyrazoles. , 1996, Cancer treatment reviews.
[17] R. Agarwal,et al. Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. , 1997, Journal of the National Cancer Institute.
[18] Peter C. Fox,et al. Comparative molecular field analysis and molecular modeling studies of 20-(S)- camptothecin analogs as inhibitors of DNA topoisomerase I and anticancer/antitumor agents , 1997, J. Comput. Aided Mol. Des..
[19] J. Wang,et al. Structural similarities between topoisomerases that cleave one or both DNA strands. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[20] J. Nitiss. Investigating the biological functions of DNA topoisomerases in eukaryotic cells. , 1998, Biochimica et biophysica acta.
[21] N. Osheroff,et al. Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme. , 1998, Biochimica et biophysica acta.
[22] L. Kaczmarek,et al. Synthesis, and cytotoxic activity of some novel indolo[2,3-b]quinoline derivatives: DNA topoisomerase II inhibitors. , 1999, Bioorganic & medicinal chemistry.
[23] M. Isemura,et al. Tea catechins and related polyphenols as anti-cancer agents. , 2000, BioFactors.
[24] Toxicology of benzyl alcohols: a QSAR analysis. , 2000, Chemosphere.
[25] S. Gupta,et al. Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells. , 2000, Archives of biochemistry and biophysics.
[26] J. Haber. Partners and pathwaysrepairing a double-strand break. , 2000, Trends in genetics : TIG.
[27] N. Osheroff,et al. Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice. , 2000, Progress in nucleic acid research and molecular biology.
[28] L. Pogliani. From molecular connectivity indices to semiempirical connectivity terms: recent trends in graph theoretical descriptors. , 2000, Chemical reviews.
[29] D. V. Von Hoff,et al. 7- and 10-substituted camptothecins: dependence of topoisomerase I-DNA cleavable complex formation and stability on the 7- and 10-substituents. , 2000, Molecular pharmacology.
[30] S. Gupta,et al. Green tea constituent (--)-epigallocatechin-3-gallate inhibits topoisomerase I activity in human colon carcinoma cells. , 2001, Biochemical and biophysical research communications.
[31] J. Champoux. DNA topoisomerases: structure, function, and mechanism. , 2001, Annual review of biochemistry.
[32] C. Hansch,et al. Comparative QSAR studies on bibenzimidazoles and terbenzimidazoles inhibiting topoisomerase I. , 2001, Bioorganic & medicinal chemistry.
[33] J. Hoeijmakers,et al. Chromosomal stability and the DNA double-stranded break connection , 2001, Nature Reviews Genetics.
[34] C. Selassie,et al. QSAR: then and now. , 2002, Current topics in medicinal chemistry.
[35] A. Tropsha,et al. Beware of q2! , 2002, Journal of molecular graphics & modelling.
[36] C. Hansch,et al. Comparative QSAR and the radical toxicity of various functional groups. , 2002, Chemical reviews.
[37] A. Leo,et al. Chem-bioinformatics: comparative QSAR at the interface between chemistry and biology. , 2002, Chemical reviews.
[38] Corwin Hansch,et al. On the Role of Polarizability in Chemical-Biological Interactions , 2003, J. Chem. Inf. Comput. Sci..
[39] Paola Gramatica,et al. The Importance of Being Earnest: Validation is the Absolute Essential for Successful Application and Interpretation of QSPR Models , 2003 .
[40] N. Osheroff,et al. A Two-drug Model for Etoposide Action against Human Topoisomerase IIα* , 2003, The Journal of Biological Chemistry.
[41] Y. Pommier,et al. Non-camptothecin DNA topoisomerase I inhibitors in cancer therapy. , 2003, Current topics in medicinal chemistry.
[42] K. Kohn,et al. Apoptosis induced by topoisomerase inhibitors. , 2003, Current medicinal chemistry. Anti-cancer agents.
[43] Corwin Hansch,et al. QSAR of Chemical Polarizability and Nerve Toxicity. 2 , 2003, J. Chem. Inf. Comput. Sci..
[44] C. Monneret,et al. Etoposide: discovery and medicinal chemistry. , 2004, Current medicinal chemistry.
[45] S. Hecht,et al. Water-soluble camptothecin derivatives that are intrinsic topoisomerase I poisons. , 2004, Organic letters.
[46] M. Ratain,et al. Pharmacodynamics and long-term toxicity of etoposide , 2004, Cancer Chemotherapy and Pharmacology.
[47] L. Doyle,et al. Etoposide: current status and future perspectives in the management of malignant neoplasms , 2004, Cancer Chemotherapy and Pharmacology.
[48] L. Corcos,et al. Topoisomerase I and II inhibitors control caspase-2 pre-messenger RNA splicing in human cells. , 2004, Molecular cancer research : MCR.
[49] T. Nagasu,et al. Synthesis and evaluation of novel pyrimido-acridone, -phenoxadine, and -carbazole as topoisomerase II inhibitors. , 2004, Chemical & pharmaceutical bulletin.
[50] C. Hansch,et al. On the role of polarizability in QSAR. , 2005, Bioorganic & medicinal chemistry.
[51] T. Okawara,et al. Inhibitory activities against topoisomerase I and II by isoaurostatin derivatives and their structure-activity relationships. , 2005, Bioorganic & medicinal chemistry letters.
[52] C. Hansch,et al. The role of hydrophobic properties of chemicals in promoting allosteric reactions. , 2005, Bioorganic & medicinal chemistry.
[53] R. Verma. An Approach Towards the Quantitative Structure-Activity Relationships for Sulfamate-Based Estrone Sulfatase Inhibitors , 2005 .
[54] C. Dekker,et al. Friction and torque govern the relaxation of DNA supercoils by eukaryotic topoisomerase IB , 2005, Nature.
[55] C. Selassie,et al. Cellular apoptosis and cytotoxicity of phenolic compounds: a quantitative structure-activity relationship study. , 2005, Journal of medicinal chemistry.
[56] R. Verma. Understanding topoisomerase I and II in terms of QSAR. , 2005, Bioorganic & medicinal chemistry.
[57] E. LaVoie,et al. Esters and amides of 2,3-dimethoxy-8,9-methylenedioxy-benzo[i]phenanthridine-12-carboxylic acid: potent cytotoxic and topoisomerase I-targeting agents. , 2005, Bioorganic & Medicinal Chemistry.
[58] Novel carbamate derivatives of 4-beta-amino-4'-O-demethyl-4-desoxypodophyllotoxin as inhibitors of topoisomerase II: synthesis and biological evaluation. , 2005, Organic & biomolecular chemistry.
[59] Y. Pommier,et al. Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex. , 2005, Journal of medicinal chemistry.
[60] C. Hansch,et al. A comparison between two polarizability parameters in chemical--biological interactions. , 2005, Bioorganic & medicinal chemistry.
[61] E. LaVoie,et al. 6-Substituted 6H-dibenzo[c,h][2,6]naphthyridin-5-ones: reversed lactam analogues of ARC-111 with potent topoisomerase I-targeting activity and cytotoxicity. , 2006, Bioorganic & medicinal chemistry.
[62] C. Hansch,et al. Cytotoxicity of organic compounds against ovarian cancer cells: a quantitative structure-activity relationship study. , 2006, Molecular pharmaceutics.
[63] Hong Liang,et al. A Structure-Based 3D-QSAR Study of Anthrapyrazole Analogues of the Anticancer Agents Losoxantrone and Piroxantrone , 2006, J. Chem. Inf. Model..
[64] Xiaona Li,et al. Preparation of yuanhuacine and relative daphne diterpene esters from Daphne genkwa and structure-activity relationship of potent inhibitory activity against DNA topoisomerase I. , 2006, Bioorganic & medicinal chemistry.
[65] Y. Pommier. Topoisomerase I inhibitors: camptothecins and beyond , 2006, Nature Reviews Cancer.
[66] P. Khadikar,et al. QSAR study on topically acting sulfonamides incorporating GABA moieties: a molecular connectivity approach. , 2006, Bioorganic & medicinal chemistry letters.
[67] Sang Kook Lee,et al. Synthesis, cytotoxicity, and DNA topoisomerase II inhibitory activity of benzofuroquinolinediones. , 2007, Bioorganic & medicinal chemistry.
[68] C. Hansch,et al. Understanding human rhinovirus infections in terms of QSAR. , 2007, Virology.
[69] P. Fenaux,et al. Predisposition to therapy-related acute leukemia with balanced chromosomal translocations does not result from a major constitutive defect in DNA double-strand break end joining. , 2007, Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis.